Editor`s Picks

Gold surged to a fresh high this week, while silver also closed positively despite the US dollar strength. Factors like inflation concerns and anticipated Fed rate cuts are bolstering precious...

U.S. jobs report, PMI surveys, Fed speakers will be in focus this week. Fortinet is a buy as its annual ‘Accelerate 2024’ event kicks off. Tesla is a sell with weak Q1 deliveries...

The final estimate for Q4 GDP growth in the U.S. is revised up to 3.4%, fueled by robust consumer spending and nonresidential fixed investment. A slight decrease in jobless claims to 210,000 further...

The S&P 500 closed out a blowout month and quarter at a new record high to notch its best start to a year since 2019. Identifying promising opportunities becomes paramount amid the current...

After a sluggish 2023, 2024 looks brighter for healthcare stocks. Numerous demographic and social factors also argue in favor of a long-term rise. What are the best healthcare stocks to buy...

Despite a challenging year with a stock price drop of over 41%, ACADIA Pharmaceuticals is seen by InvestingPro and Wall Street analysts as undervalued, with expectations of significant upside...

As US index futures hint at a subdued start today amid lingering concerns about stretched valuations, especially on the S&P 500. Awaiting key data releases, investors remain watchful for any...

Central Banks had a big impact on gold and silver last week. Gold futures have made new highs - and traders should watch out for a potential correction because of PCE, GDP data. Meanwhile, silver...